ArticleFrontiers in cardiovascular medicine2025
Analysis of risk factors and application of risk management strategies in hemodialysis patients complicated with heart failure.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Burden of Heart Failure in End-Stage Renal Disease: Insights from a Retrospective Cohort of Hemodialysis Patients.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) is a common and serious complication in maintenance hemodialysis (MHD) patients, significantly affecting their prognosis and quality of life. This study aims to identify risk factors for HF and evaluate targeted, risk-based nursing interventions. Methods: A total of 170 MHD patients admitted between January 2022 and January 2024 were divided into HF ( Results: Univariate analysis identified age (OR = 1.076), dialysis duration (OR = 1.054), hypertension (OR = 3.391), diabetes (OR = 2.874), coronary heart disease (OR = 3.115), smoking history (OR = 1.976), HbA1c (OR = 18.675), and C-reactive protein (CRP; OR = 1.466) as risk factors for HF in MHD patients ( Conclusion: Age, hyperglycemia, inflammation, and comorbidities (hypertension, diabetes, coronary heart disease) independently increase HF risk in MHD patients. Targeted risk management reduces psychological distress, complications, and enhances care outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.